Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Sep 11, 2024 4:45pm
326 Views
Post# 36219262

RE:RE:RE:RE:RE:RE:RE:RE:Kirk Look to speak today

RE:RE:RE:RE:RE:RE:RE:RE:Kirk Look to speak todayI WAS invested in ONCY for 20 years... finally got very tired of waiting for the 'pivotal' year. Brad's timelines were fantasy, as were Matt's... and now Kirk..?

There is potential here... but to date management have incapable of demonstrating this, the market cap is testament to this... the reason for questioning the true 'pivot' point is HOW do they get to that point, and derisk an investment, they don't even have the cash to even start...

It's clear they need to raise... and the most likely route is another reverse split, sold to investors as being necessary or greater gains... after the split might be far better time, as generally stocks drop immediaetly afterwards

My thesis is, WHY hold this now, when dilution is coming (they're going it alone remember). Better to wait, make money on other stocks and jump back in closer to the real pivot.

Kirk has spoken, and look how the market has reacted, again... another fireside chat, another drop on below average volume...  IF pivotal data were immiment, where are the buyers. This company is tired. Where is Matt... odd that he disappeared immediately prior to the Type C meeting outcome with FDA... which was another nothing burger.

Remember when Noteable was telling you this company's value proposition was because of the value Pela would make for a CPI company for triplet combo for mBC - that ship has sailed. For over 4 years him and that nutjob Canaduh have been shilling this dog as the next NVidia..

invest now or wait until the path (and funding) is asbolutely clear... there will still be time to jump on board if this has legs...

<< Previous
Bullboard Posts
Next >>